Diseases, Conditions, Syndromes

Promising results from in vitro combination therapy against COVID-19

Researchers at Karolinska Institutet in Sweden report promising results from an in vitro combination therapy against COVID-19. In a study published in EMBO Molecular Medicine, the researchers show that a combination of remdesivir, ...

Medical research

New mouse model for hepatitis C

Hepatitis C affects about three million people in the U.S. and is a leading cause of chronic liver disease, so creating a vaccine and new treatments is an important public health goal. Most research to date has been done ...

Diseases, Conditions, Syndromes

New antivirals for influenza and Zika

Amyloids are particular protein assemblies with properties similar to silk, that serve numerous functions. They also form upon protein misfolding resulting in protein inactivation.

Medical research

Fatty acids could lead to flu drug

Flu viruses are a major cause of death and sickness around the world, and antiviral drugs currently do not protect the most seriously ill patients. A study published March 7th by Cell Press in the journal Cell reveals that ...

Oncology & Cancer

Virus shows promise for imaging and treating pancreatic cancer

Researchers are investigating a potential treatment and noninvasive imaging modality for pancreatic cancer that shows promise, according to researchers at Memorial Sloan-Kettering Cancer Center in New York, N.Y., and Genelux ...

HIV & AIDS

Certain mutations give HIV infection an advantage that sticks

(Medical Xpress)—Varieties of HIV that replicate more quickly can cause infected individuals' immune systems to decline faster, new research demonstrates. The results were published by the journal PLOS Pathogens.

HIV & AIDS

Replication of immunodeficiency virus in humans

Drs. Beatrice Hahn and Frank Kirchoff led an international research effort to understand what adaptations allow a chimpanzee strain of SIV to replicate in human tissues.

page 25 from 40